BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 16765382)

  • 1. Metal changes in CSF and peripheral compartments of parkinsonian patients.
    Bocca B; Alimonti A; Senofonte O; Pino A; Violante N; Petrucci F; Sancesario G; Forte G
    J Neurol Sci; 2006 Oct; 248(1-2):23-30. PubMed ID: 16765382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary Copper Intake and Risk of Parkinson's Disease: a Cross-sectional Study.
    Zeng Z; Cen Y; Xiong L; Hong G; Luo Y; Luo X
    Biol Trace Elem Res; 2024 Mar; 202(3):955-964. PubMed ID: 37462848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis.
    Zhao Y; Ray A; Portengen L; Vermeulen R; Peters S
    Am J Epidemiol; 2023 Jul; 192(7):1207-1223. PubMed ID: 37022311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration.
    Maier JAM; Locatelli L; Fedele G; Cazzaniga A; Mazur A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facets of ICP-MS and their potential in the medical sciences-Part 1: fundamentals, stand-alone and hyphenated techniques.
    Clases D; Gonzalez de Vega R
    Anal Bioanal Chem; 2022 Oct; 414(25):7337-7361. PubMed ID: 36028724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced Neurodegeneration.
    Teil M; Doudnikoff E; Thiolat ML; Bohic S; Bezard E; Dehay B
    Mol Neurobiol; 2022 Oct; 59(10):6245-6259. PubMed ID: 35915387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPL6: A Key Molecule Regulating Zinc- and Magnesium-Bound Metalloproteins of Parkinson's Disease.
    Anirudhan A; Angulo-Bejarano PI; Paramasivam P; Manokaran K; Kamath SM; Murugesan R; Sharma A; Ahmed SSSJ
    Front Neurosci; 2021; 15():631892. PubMed ID: 33790735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells.
    Sun Y; Kamat A; Singh BB
    Front Physiol; 2020; 11():305. PubMed ID: 32390858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.
    Kalita J; Kumar V; Misra UK; Bora HK
    Neurotox Res; 2020 Apr; 37(4):904-912. PubMed ID: 31811585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson's Disease.
    Shen X; Yang H; Zhang D; Jiang H
    Front Neurosci; 2019; 13():939. PubMed ID: 31616238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNPs rs11240569, rs708727, and rs823156 in
    Cibulka M; Brodnanova M; Grendar M; Grofik M; Kurca E; Pilchova I; Osina O; Tatarkova Z; Dobrota D; Kolisek M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson's Disease.
    Sanyal J; Anirudhan A; Banerjee TK; Guha G; Ramakrishnan Veerabathiran ; Murugesan R; Ahmed SSJS; Rao VR
    Cell Mol Neurobiol; 2020 Apr; 40(3):357-367. PubMed ID: 31512170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium-Induced Cell Survival Is Dependent on TRPM7 Expression and Function.
    Sun Y; Sukumaran P; Singh BB
    Mol Neurobiol; 2020 Jan; 57(1):528-538. PubMed ID: 31392516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.
    Dos Santos AB; Bezerra MA; Rocha ME; Barreto GE; Kohlmeier KA
    J Neural Transm (Vienna); 2019 Oct; 126(10):1291-1301. PubMed ID: 31297591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.
    Sarkar A; Rawat N; Sachan N; Singh MP
    Neurotox Res; 2019 Oct; 36(3):627-644. PubMed ID: 31267488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.
    Sturgeon M; Wu P; Cornell R
    J Neurol Neuromedicine; 2016; 1(9):23-28. PubMed ID: 31187092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating magnesium levels in patients with Parkinson's disease: a meta-analysis.
    Jin X; Liu MY; Zhang DF; Gao H; Wei MJ
    Neuropsychiatr Dis Treat; 2018; 14():3159-3168. PubMed ID: 30510425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Magnesium in Neurological Disorders.
    Kirkland AE; Sarlo GL; Holton KF
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29882776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human predisposition to cognitive impairment and its relation with environmental exposure to potentially toxic elements.
    Cabral Pinto MMS; Marinho-Reis AP; Almeida A; Ordens CM; Silva MMVG; Freitas S; Simões MR; Moreira PI; Dinis PA; Diniz ML; Ferreira da Silva EA; Condesso de Melo MT
    Environ Geochem Health; 2018 Oct; 40(5):1767-1784. PubMed ID: 28281140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of environmental and occupational exposure to heavy metals in Taranto and other provinces of Southern Italy by means of scalp hair analysis.
    Buononato EV; De Luca D; Galeandro IC; Congedo ML; Cavone D; Intranuovo G; Guastadisegno CM; Corrado V; Ferri GM
    Environ Monit Assess; 2016 Jun; 188(6):337. PubMed ID: 27165601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.